A detailed history of Intech Investment Management LLC transactions in Voyager Therapeutics, Inc. stock. As of the latest transaction made, Intech Investment Management LLC holds 21,245 shares of VYGR stock, worth $84,980. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,245
Previous 26,547 19.97%
Holding current value
$84,980
Previous $82,000 19.51%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 10, 2025

SELL
$2.96 - $4.71 $15,693 - $24,972
-5,302 Reduced 19.97%
21,245 $98,000
Q2 2025

Aug 08, 2025

SELL
$2.73 - $3.64 $18,809 - $25,079
-6,890 Reduced 20.61%
26,547 $82,000
Q1 2025

May 20, 2025

BUY
$3.38 - $6.04 $38,231 - $68,318
11,311 Added 51.12%
33,437 $113,000
Q4 2024

Feb 10, 2025

BUY
$5.27 - $8.07 $49,601 - $75,954
9,412 Added 74.03%
22,126 $125,000
Q3 2024

Nov 08, 2024

BUY
$5.77 - $9.27 $73,359 - $117,858
12,714 New
12,714 $74,000

Others Institutions Holding VYGR

About Voyager Therapeutics, Inc.


  • Ticker VYGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,647,600
  • Market Cap $155M
  • Description
  • Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...
More about VYGR
Track This Portfolio

Track Intech Investment Management LLC Portfolio

Follow Intech Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intech Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intech Investment Management LLC with notifications on news.